Morphea
☆ Ann an toraidhean 2022 Stiftung Warentest às a’ Ghearmailt, cha robh sàsachd luchd-cleachdaidh le ModelDerm ach beagan nas ìsle na le co-chomhairlean telemedicine pàighte.
Mar as trice bidh an lesion aig Morphea a’ nochdadh mar phìos pigmentach atrophic.
References
Is e galar tearc a th’ ann an Scleroderma a tha a’ toirt buaidh air maothran ceangail, a’ nochdadh mar chraiceann cruaidh agus uaireannan a’ toirt buaidh air pàirtean eile den bhodhaig. Tha dà phrìomh sheòrsa ann: systemic sclerosis , a tha a’ toirt a-steach cruadhachadh craiceann agus buill-bodhaig a-staigh, agus localized scleroderma , ris an canar cuideachd morphea, a bhios mar as trice a’ fuireach cuibhrichte ris a’ chraiceann agus na maothran fodha, le cùrsa neo-sheasmhach agus fèin-chuingealaichte. Ged a tha scleroderma ionadail neo-chumanta agus nach eil an adhbhar soilleir, tha rannsachadh o chionn ghoirid a 'moladh gum faod e buaidh a thoirt air buill-bodhaig a-staigh agus a' leantainn gu diofar chùisean slàinte. Tha làimhseachadh tràth deatamach gus casg a chuir air duilgheadasan, leis cho dona sa tha localized scleroderma.
Scleroderma is a rare connective tissue disease that is manifested by cutaneous sclerosis and variable systemic involvement. Two categories of scleroderma are known: systemic sclerosis, characterized by cutaneous sclerosis and visceral involvement, and localized scleroderma or morphea which classically presents benign and self-limited evolution and is confined to the skin and/or underlying tissues. Localized scleroderma is a rare disease of unknown etiology. Recent studies show that the localized form may affect internal organs and have variable morbidity. Treatment should be started very early, before complications occur due to the high morbidity of localized scleroderma.
Scleroderma is a rare connective tissue disease that is manifested by cutaneous sclerosis and variable systemic involvement. Two categories of scleroderma are known: systemic sclerosis, characterized by cutaneous sclerosis and visceral involvement, and localized scleroderma or morphea which classically presents benign and self-limited evolution and is confined to the skin and/or underlying tissues. Localized scleroderma is a rare disease of unknown etiology. Recent studies show that the localized form may affect internal organs and have variable morbidity. Treatment should be started very early, before complications occur due to the high morbidity of localized scleroderma.
Tha Morphea , ris an canar cuideachd scleroderma ionadail, na ghalar fèin-dìon tearc a bheir buaidh air inneal ceangail. Faodaidh e nochdadh ann an diofar dhòighean, agus chan eil e gu math cumanta, le timcheall air 0. 4 - 2. 7 cùisean gach 100,000 neach gach bliadhna. Morphea gu tric ri fhaicinn ann an clann eadar 2 agus 14 bliadhna a dh'aois, agus tha e buailteach buaidh a thoirt air nigheanan nas trice na balaich.
Morphea (localized scleroderma) is a rare autoimmune connective tissue disease with variable clinical presentations, with an annual incidence of 0.4-2.7 cases per 100,000. Morphea occurs most frequently in children aged 2-14 years, and the disease exhibits a female predominance.
Morphea (localized scleroderma) is a rare autoimmune connective tissue disease with variable clinical presentations, with an annual incidence of 0.4-2.7 cases per 100,000. Morphea occurs most frequently in children aged 2-14 years, and the disease exhibits a female predominance.
Tha morphea na ghalar glè ainneamh. Air sgàth co-dhèanamh an deilbh, is dòcha gu bheil an algairim air a mhearachdachadh airson morphea.